DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 42 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 7.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,426 | -34.8% | 89,700 | +9.2% | 0.00% | – |
| Q2 2023 | $354,931 | +155.4% | 82,160 | -9.5% | 0.00% | – |
| Q1 2023 | $138,962 | -5.5% | 90,825 | -2.4% | 0.00% | – |
| Q4 2022 | $147,057 | +31.3% | 93,068 | +3.1% | 0.00% | – |
| Q3 2022 | $112,000 | -45.6% | 90,254 | -11.3% | 0.00% | – |
| Q2 2022 | $206,000 | -17.6% | 101,704 | +1.8% | 0.00% | – |
| Q1 2022 | $250,000 | -33.9% | 99,942 | -1.3% | 0.00% | – |
| Q4 2021 | $378,000 | +10.2% | 101,283 | +18.4% | 0.00% | – |
| Q3 2021 | $343,000 | -9.5% | 85,570 | +0.4% | 0.00% | – |
| Q2 2021 | $379,000 | -51.3% | 85,195 | +0.2% | 0.00% | – |
| Q1 2021 | $778,000 | -36.6% | 85,026 | -29.7% | 0.00% | – |
| Q4 2020 | $1,227,000 | +147.9% | 120,989 | +3.6% | 0.00% | – |
| Q3 2020 | $495,000 | -25.5% | 116,767 | +21.8% | 0.00% | – |
| Q2 2020 | $664,000 | +1797.1% | 95,871 | +669.1% | 0.00% | – |
| Q1 2020 | $35,000 | – | 12,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |